Results 41 to 50 of about 9,727 (212)
The Pan African Medical Journal, 2021 INTRODUCTION: Membranoproliferative glomerulonephritis (MPGN) is a rare kidney disease with a poor prognosis as 50% of patients attend the end stage renal failure after 10 years of follow up. Several factors have been described associated with poor renal
Ikram Agrebi +6 more
doaj +1 more source
A Framework for Emergency Department–Integrated Hepatitis C Test‐and‐Treat in the United States
Journal of Viral Hepatitis, Volume 33, Issue 6, June 2026.ABSTRACT Despite the availability of curative, direct‐acting antiviral therapy, hepatitis C virus elimination remains incomplete. Losses across the care cascade continue to limit impact, from initial diagnosis to sustained virologic response. Fewer than 1/3 of individuals ultimately achieve cure. These gaps reflect a delivery system that does not align
Saeed S. Graham
wiley +1 more source
Secondary membranoproliferative glomerulonephritis
Kidney International, 1995 A 37-year-old man was transferred to Brigham and Women's Hospital for evaluation of progressive renal failure. His medical history was notable for intravenous drug use and heavy ethanol consumption but he denied their use for the last 7 years. He had had at least one bout of alcoholic hepatitis, which was diagnosed about 8 years previously. The patient
openaire +2 more sources
Cardiac Angiosarcoma-Associated Membranoproliferative Glomerulonephropathy
Case Reports in Medicine, 2011 Primary cardiac angiosarcoma is a rare cardiac tumor. The initial clinical course is often asymptomatic, and metastatic disease is present in a majority of affected patients at diagnosis.
Lokesh Shahani +2 more
doaj +1 more source
Membranoproliferative Glomerulonephritis Associated with Nivolumab Therapy
Case Reports in Nephrology, 2020 Nivolumab is an immune checkpoint inhibitor that targets programmed death-1 on T cells and is designed to amplify an immunologic reaction against cancer cells.
Jessica Cruz-Whitley +3 more
doaj +1 more source
Nephrology, Volume 31, Issue 6, June 2026.ABSTRACT Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) is a form of monoclonal gammopathy of renal significance (MGRS) in which monoclonal immunoglobulin deposits are found within the glomerulus, without involvement of other renal compartments.
Hayley J. Duxbury +5 more
wiley +1 more source
BMC Nephrology, 2020 Background C3 glomerulonephritis is a recently described entity with heterogeneous histopathological features. This study was conducted to assess the effect of reclassification of C3 glomerulopathies on renal outcomes, mortality, and response to therapy.
P. Puri +5 more
doaj +1 more source
eJHaem, 2023 Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in western countries. The association between CLL and glomerular disease (GD) is rare. The most frequent GD associated with CLL is membranoproliferative membranous glomerulonephritis (
Angela Rago +3 more
doaj +1 more source
Advanced Science, Volume 13, Issue 29, 22 May 2026.An entity‐centric foundation model, GloPath, is introduced for comprehensive glomerular lesion assessment from routine renal biopsy images. Trained on over one million glomeruli, the framework enables robust lesion recognition, grading, and cross modality diag nosis, while uncovering large‐scale clinicopathological associations.
Qiming He +28 more
wiley +1 more source
Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis [PDF]
, 2022 Hannah J. Lomax-Browne +24 more
openalex +1 more source